We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Consumer Discretionary 10.52%
3 Financials 9.9%
4 Healthcare 8.91%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARC
5001
DELISTED
ARC Document Solutions, Inc.
ARC
$7K ﹤0.01%
1,912
+812
+74% +$2.44K
RIBT
5002
DELISTED
RiceBran Technologies
RIBT
$7K ﹤0.01%
+2,110
New +$10.3K
JUN.U
5003
DELISTED
Juniper II Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
JUN.U
$7K ﹤0.01%
+652
New +$6.62K
HHR
5004
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$7K ﹤0.01%
147
-518
-78% -$28.2K
ABEO icon
5005
Abeona Therapeutics
ABEO
$425M
$6K ﹤0.01%
760
-1,491
-66% -$27.4K
ASTC icon
5006
Astrotech Corp
ASTC
$17.9M
$6K ﹤0.01%
+290
New +$7.64K
FABC
5007
Fabric.AI Inc
FABC
$18M
$6K ﹤0.01%
30
-55
-65% -$17.7K
BIV icon
5008
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$6K ﹤0.01%
70
+13
+23% +$1.15K
BMRA icon
5009
Biomerica
BMRA
$4.85M
$6K ﹤0.01%
+189
New +$7.28K
BTMD icon
5010
Biote Corp
BTMD
$40.7M
$6K ﹤0.01%
608
+68
+13% +$664
CEE
5011
Central and Eastern Europe Fund
CEE
$140M
$6K ﹤0.01%
+235
New +$6.75K
CKX icon
5012
CKX Lands
CKX
$22.4M
$6K ﹤0.01%
512
+195
+62% +$2.27K
CNTX icon
5013
Context Therapeutics
CNTX
$46.5M
$6K ﹤0.01%
+2,054
New +$10.2K
CWBC
5014
Community West Bancshares
CWBC
$706M
$6K ﹤0.01%
314
+101
+47% +$2.15K
DAIO icon
5015
Data I/O
DAIO
$30.8M
$6K ﹤0.01%
1,265
+211
+20% +$1.13K
EDD
5016
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$375M
$6K ﹤0.01%
+1,166
New +$6.66K
ELEV
5017
DELISTED
Elevation Oncology
ELEV
$6K ﹤0.01%
+995
New +$6.87K
EOI
5018
Eaton Vance Enhanced Equity Income Fund
EOI
$830M
$6K ﹤0.01%
+300
New +$5.85K
EPP icon
5019
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
$6K ﹤0.01%
+135
New +$6.68K
ESP icon
5020
Espey Mfg & Electronics Corp
ESP
$195M
$6K ﹤0.01%
388
-208
-35% -$3.02K
FCT
5021
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
$6K ﹤0.01%
500
+273
+120% +$3.28K
FEM icon
5022
First Trust Emerging Markets AlphaDEX Fund
FEM
$788M
$6K ﹤0.01%
+225
New +$5.87K
FNWB icon
5023
First Northwest Bancorp
FNWB
$107M
$6K ﹤0.01%
+301
New +$5.58K
FXI icon
5024
iShares China Large-Cap ETF
FXI
$4.16B
$6K ﹤0.01%
+170
New +$6.67K
GENI icon
5025
Genius Sports
GENI
$2.12B
$6K ﹤0.01%
836
+437
+110% +$5.89K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.